Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
ES502 in Pancreatic Cancer: NCT07649928 Clinical Landscape Report 2026
18 September 2026
NCT07649928 clinical landscape for Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Evexomostat in Prostate Cancer, Familial: ACTRN12626000736347 Clinical Landscape Report 2026
18 September 2026
ACTRN12626000736347 clinical landscape for Prostate Cancer, Familial: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
![[68Ga]Ga-A9-6217 (Alpha-9 Oncology USA Inc.) in Breast Cancer: NCT07661641 Clinical Landscape Report 2026](https://synapse-static-patsnap-com.libproxy1.nus.edu.sg/strapi-static/Blog_cover_B_105_21748b7b06.jpg)
9 min read
[68Ga]Ga-A9-6217 (Alpha-9 Oncology USA Inc.) in Breast Cancer: NCT07661641 Clinical Landscape Report 2026
18 September 2026
NCT07661641 clinical landscape for Breast Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
177Lu-PSMA-VG-01 in PSMA-Positive Castration-Resistant Prostatic Cancer: NCT07660211 Clinical Landscape Report 2026
18 September 2026
NCT07660211 clinical landscape for PSMA-Positive Castration-Resistant Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and dev…
9 min read
Probucol in Parkinson Disease: ACTRN12626000740392 Clinical Landscape Report 2026
18 September 2026
ACTRN12626000740392 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sulfamethoxazole/Trimethoprim in Pulmonary Disease, Chronic Obstructive: NCT07665359 Clinical Landscape Report 2026
18 September 2026
NCT07665359 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Levodopa hydrate in Parkinson Disease: ACTRN12626000769381 Clinical Landscape Report 2026
18 September 2026
ACTRN12626000769381 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ontunisertib in Crohn Disease: NCT07672574 Clinical Landscape Report 2026
18 September 2026
NCT07672574 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Gallium GA-68 Gozetotide in Metastatic Castration-Sensitive Prostate Carcinoma: NCT07674771 Clinical Landscape Report 2026
18 September 2026
NCT07674771 clinical landscape for Metastatic Castration-Sensitive Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and deve…
9 min read
Sevoflurane in Kidney Failure, Chronic: NCT07678073 Clinical Landscape Report 2026
18 September 2026
NCT07678073 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Darolutamide in Localized Prostate Carcinoma: NCT07677566 Clinical Landscape Report 2026
18 September 2026
NCT07677566 clinical landscape for Localized Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LY-N001(Lingyi (Hangzhou) Biotechnology) in Parkinson Disease: NCT07685444 Clinical Landscape Report 2026
18 September 2026
NCT07685444 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.